Our group has accumulated a large body of evidence suggesting that the small molecule specifically and effectively inhibited Gli1 and Gli2 both in vivo and in vitro, dramatically suppressed tumor growth in several tumor types, such as lung cancer, melanoma and MPM as reported here, and had a very low toxicity profile in vivo. The gene discussed is GLI2; the disease is lung cancer.